UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045057
Receipt number R000051431
Scientific Title Clinical study for premature ejaculation with Men's Training Cup Keep Training
Date of disclosure of the study information 2021/08/04
Last modified on 2021/11/25 18:08:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study for premature ejaculation with Men's Training Cup Keep Training

Acronym

Clinical study for premature ejaculation with Men's Training Cup Keep Training

Scientific Title

Clinical study for premature ejaculation with Men's Training Cup Keep Training

Scientific Title:Acronym

Clinical study for premature ejaculation with Men's Training Cup Keep Training

Region

Japan


Condition

Condition

premature ejaculation

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

improvement for premature ejaculation

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

IELT (Intravaginal Ejaculation Latency Time)

Key secondary outcomes

PEDT (Premature Ejaculation Diagnostic Tool)
SHIM (Sexual Health Inventory for Men)
EHS (Erection Hardness Score)
DPSIQ-5 (Difficulty in Performing Sexual Intercourse Questionnaire-5)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male

Key inclusion criteria

premature ejaculation

Key exclusion criteria

uncontrollable diabetes mellitus
neurogenic disease
antidepressant drug
alpha1-adrenergic receptor
5alpha-reductase inhibitor

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Akira
Middle name
Last name Tsujimura

Organization

Juntendo University Urayasu Hospital

Division name

Department of Urology

Zip code

2790021

Address

2-1-1 Tomioka, Urayasu city, Chiba, Japan

TEL

0473533111

Email

atsujimu@juntendo.ac.jp


Public contact

Name of contact person

1st name MASATO
Middle name
Last name SHIRAI

Organization

Juntendo University Urayasu Hospital

Division name

Department of Urology

Zip code

2790021

Address

2-1-1 Tomioka, Urayasu city, Chiba, Japan

TEL

0473533111

Homepage URL


Email

masatos@juntendo-urayasu.jp


Sponsor or person

Institute

Department of Urology, Juntendo University Urayasu Hospital

Institute

Department

Personal name



Funding Source

Organization

Juntendo University Urayasu Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

EAST clinic Shinjuku
EAST clinic Shinbashi

Name of secondary funder(s)

none


IRB Contact (For public release)

Organization

Juntendo University Urayasu Hospital

Address

2-1-1 Tomioka, Urayasu city, Chiba, Japan

Tel

0473533111

Email

rinri-urayasu@juntendo-urayasu.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学医学部附属浦安病院(千葉県)
イースト駅前クリニック新宿院(東京都)
イースト駅前クリニック新橋院(東京都)


Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 04 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

37

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 04 Month 14 Day

Date of IRB

2020 Year 04 Month 14 Day

Anticipated trial start date

2021 Year 02 Month 22 Day

Last follow-up date

2021 Year 09 Month 30 Day

Date of closure to data entry

2021 Year 09 Month 30 Day

Date trial data considered complete

2021 Year 09 Month 30 Day

Date analysis concluded

2021 Year 12 Month 31 Day


Other

Other related information

study duration is 2-month


Management information

Registered date

2021 Year 08 Month 04 Day

Last modified on

2021 Year 11 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051431


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name